Issue 2/2009
Content (19 Articles)
Mammary field cancerization: molecular evidence and clinical importance
Christopher M. Heaphy, Jeffrey K. Griffith, Marco Bisoffi
Cancer stem cells in breast cancer and metastasis
Jessica C. Lawson, Gregory L. Blatch, Adrienne L. Edkins
The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review
Li-Fen Chao, Anthony Lin Zhang, Hsueh-Erh Liu, Ming-Huei Cheng, Hung-Bun Lam, Sing Kai Lo
Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha
Gregory E. Weitsman, Wineeta Weebadda, Kanyarat Ung, Leigh C. Murphy
Sodium phenylacetate inhibits the Ras/MAPK signaling pathway to induce reduction of the c-Raf-1 protein in human and canine breast cancer cells
Manabu Watanabe, Nozomi Miyajima, Maki Igarashi, Yoshifumi Endo, Natsuko Watanabe, Sumio Sugano
Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines
Ling Lai, Lin Yuan, Qi Cheng, Chunmin Dong, Lulu Mao, Steven Marc Hill
Synergistic effect of bisphosphonate and docetaxel on the growth of bone metastasis in an animal model of established metastatic bone disease
E. R. van Beek, C. W. G. M. Lowik, J. van Wijngaarden, F. H. Ebetino, S. E. Papapoulos
Three-dimensional scapulothoracic motion following treatment for breast cancer
Delva Shamley, Ragavan Srinaganathan, Reza Oskrochi, Ion Lascurain-Aguirrebeña, Elaine Sugden
The promoter C specific ERα isoform is associated with tamoxifen outcome in breast cancer
Sandra Amaral, Werner Schroth, Sibylle Kugler, Peter Fritz, Wolfgang Simon, Hiltrud Brauch
Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas
Helena Wensman, Hanna Göransson, Karl-Johan Leuchowius, Sara Strömberg, Fredrik Pontén, Anders Isaksson, Gerard Roel Rutteman, Nils-Erik Heldin, Gunnar Pejler, Eva Hellmén
Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome
Eun-Young Oh, Patricia A. Wood, Xiaoming Yang, William J. M. Hrushesky
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer
John W. Smith II, Kristi J. McIntyre, Patrick V. Acevedo, Carlos A. Encarnacion, Karen L. Tedesco, Yunfei Wang, Lina Asmar, Joyce A. O’Shaughnessy
The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer
Meng-Fen Wu, S. G. Hilsenbeck, Yee L. Tham, Rita Kramer, R. M. Elledge, J. C. Chang, L. C. Friedman
Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients
Orit Freedman, Eitan Amir, George Dranitsaris, Julie Napolskikh, Ritu Kumar, Michael Fralick, Stephen Chia, Teresa Petrella, Susan Dent, Katia Tonkin, Imran Ahmad, Daniel Rayson, Mark Clemons
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure
E. Montagna, G. Viale, N. Rotmensz, P. Maisonneuve, V. Galimberti, A. Luini, M. Intra, P. Veronesi, G. Mazzarol, G. Pruneri, G. Renne, R. Torrisi, A. Cardillo, G. Cancello, A. Goldhirsch, M. Colleoni
Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study
Neela Guha, Marilyn L. Kwan, Charles P. Quesenberry Jr, Erin K. Weltzien, Adrienne L. Castillo, Bette J. Caan
Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk
Rongxi Yang, Bowang Chen, Kari Hemminki, Barbara Wappenschmidt, Christoph Engel, Christian Sutter, Nina Ditsch, Bernhard H. F. Weber, Dieter Niederacher, Norbert Arnold, Alfons Meindl, Claus R. Bartram, Rita K. Schmutzler, Barbara Burwinkel
Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk
Gordon Fehringer, Norman F. Boyd, Julia A. Knight, Andrew D. Paterson, Gillian S. Dite, Graham G. Giles, Melissa C. Southey, Irene L. Andrulis, John L. Hopper, Hilmi Ozcelik
Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg
Patrik Vankrunkelsven, Eliane Kellen, Daniël Lousbergh, Edith Cloes, Lode Op de Beeck, Christel Faes, Liesbeth Bruckers, Raf Mertens, Jan W. Coebergh, Flora E. Van Leeuwen, Frank Buntinx